These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 29078260

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y, Yu M, Xu J, He M, Wang H, Kong H, Xie W.
    BMC Pulm Med; 2018 Aug 07; 18(1):130. PubMed ID: 30086741
    [Abstract] [Full Text] [Related]

  • 4. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X, Yang Y, Yang D, Tong G, Lv S, Lin X, Chen C, Dong W.
    J Vasc Surg; 2016 Nov 07; 64(5):1468-1477. PubMed ID: 26527422
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Gao H, Cheng Y, Zong L, Huang L, Qiao C, Li W, Gong B, Hu J, Liu H, Wang X, Zhao C.
    Clin Exp Hypertens; 2017 Nov 07; 39(1):34-41. PubMed ID: 28055284
    [Abstract] [Full Text] [Related]

  • 7. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML, Lucas SN, Campen MJ.
    Vascul Pharmacol; 2012 Nov 07; 56(1-2):64-73. PubMed ID: 22146233
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, Liang Y, Xing J, Wang X, Wang Y.
    Pulm Pharmacol Ther; 2018 Feb 07; 48():124-135. PubMed ID: 29133079
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
    Lin J, Chen R, Liao H, Zhang Y, Zheng Z, Hong C.
    Sci Rep; 2024 May 30; 14(1):12431. PubMed ID: 38816406
    [Abstract] [Full Text] [Related]

  • 13. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N, Zhao X, Xiang Y, Ye S, Huang J, Hu W, Lv L, Zeng C.
    Int J Cardiol; 2016 Oct 15; 221():587-96. PubMed ID: 27420584
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response.
    Luan Y, Chao S, Ju ZY, Wang J, Xue X, Qi TG, Cheng GH, Kong F.
    Int Immunopharmacol; 2015 May 15; 26(1):188-93. PubMed ID: 25601497
    [Abstract] [Full Text] [Related]

  • 15. Hydrogen ameliorates pulmonary hypertension in rats by anti-inflammatory and antioxidant effects.
    Kishimoto Y, Kato T, Ito M, Azuma Y, Fukasawa Y, Ohno K, Kojima S.
    J Thorac Cardiovasc Surg; 2015 Sep 15; 150(3):645-54.e3. PubMed ID: 26095621
    [Abstract] [Full Text] [Related]

  • 16. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY, Cai ZY, Pu J, Li J, Shen JY, Yang CD, He B.
    Inflammation; 2017 Jun 15; 40(3):806-817. PubMed ID: 28213866
    [Abstract] [Full Text] [Related]

  • 17. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Huang W, Zhou H, He Y, Wang A, Wang B, Chen Y, Liu C, Wang H, Xie W, Kong H.
    Exp Cell Res; 2024 Aug 01; 441(1):114154. PubMed ID: 38996959
    [Abstract] [Full Text] [Related]

  • 18. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay É, Biardel S, Racine C, Courture C, Bonnet P, Majka SM, Deshaies Y, Picard F, Provencher S, Bonnet S.
    J Am Heart Assoc; 2013 Jan 16; 2(1):e005157. PubMed ID: 23525442
    [Abstract] [Full Text] [Related]

  • 19. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A, Najafipour H, Joukar S, Rajabi S, Iranpour M, Kordestani Z.
    Clin Exp Hypertens; 2021 Apr 03; 43(3):270-280. PubMed ID: 33322932
    [Abstract] [Full Text] [Related]

  • 20. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH, Park BK, Oh KS, Yi KY, Lim CJ, Seo HW, Lee BH.
    Int Immunopharmacol; 2016 Nov 03; 40():196-202. PubMed ID: 27611861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.